The history of Chagas disease

被引:106
作者
Steverding, Dietmar [1 ]
机构
[1] Univ E Anglia, Biomed Res Ctr, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England
来源
PARASITES & VECTORS | 2014年 / 7卷
关键词
Chagas disease; American trypanosomiasis; History; Trypanosoma cruzi; TRYPANOSOMA-CRUZI; AMERICAN TRYPANOSOMIASIS; NEOTROPICAL BATS; UNITED-STATES; DISCOVERY; EVOLUTION; TRANSMISSION; ANCIENT; LESSONS; AFRICAN;
D O I
10.1186/1756-3305-7-317
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The ancestor of Trypanosome cruzi was probably introduced to South American via bats approximately 7-10 million years ago. When the first humans arrived in the New World, a sylvatic cycle of Chagas disease was then already well established. Paleoparasitological data suggests that human American trypanosomiasis originated in the Andean area when people founded the first settlements in the coastal region of the Atacama Desert. Identification of T. cruzi as the etiological agent and triatome bugs as the transmission vector of Chagas disease occurred within a few years at the beginning of the 20th century. History also teaches us that human activity leading to environmental changes, in particular deforestation, is the main cause for the spread of Chagas disease. Recently, migration of T. cruzi-infected patients has led to a distribution of Chagas disease from Latin America to non-endemic countries in Europe, North America and western Pacific region.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Analysis of an acute Chagas disease outbreak in the Brazilian Amazon: human cases, triatomines, reservoir mammals and parasites
    da Silva Valente, Sebastiao Aldo
    Valente, Vera da Costa
    das Neves Pinto, Ana Yece
    Barbosa Cesar, Maria de Jesus
    dos Santosb, Marivaldo Picanco
    Sa Miranda, Clovis Omar
    Cuervo, Patricia
    Fernandes, Octavio
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2009, 103 (03) : 291 - 297
  • [42] The epidemiology of Chagas disease in the Americas
    Cucunuba, Zulma M.
    Gutierrez-Romero, Sebastian A.
    Ramirez, Juan-David
    Velasquez-Ortiz, Natalia
    Ceccarelli, Soledad
    Parra-Henao, Gabriel
    Henao-Martinez, Andres F.
    Rabinovich, Jorge
    Basanez, Maria-Gloria
    Nouvellet, Pierre
    Abad-Franch, Fernando
    LANCET REGIONAL HEALTH-AMERICAS, 2024, 37
  • [43] Systematic Review of the Epidemiology of Chagas Disease in the Americas: a Call for Standardized Reporting of Chagas Disease Prevalence
    Miranda-Schaeubinger, Monica
    Chakravarti, Indira
    Freitas Lidani, Karita Claudia
    Omidian, Zahra
    Gilman, Robert H.
    CURRENT TROPICAL MEDICINE REPORTS, 2019, 6 (01) : 23 - 34
  • [44] Chagas Disease: Current View of an Ancient and Global Chemotherapy Challenge
    Martin-Escolano, Javier
    Medina-Carmona, Encarnacion
    Martin-Escolano, Ruben
    ACS INFECTIOUS DISEASES, 2020, 6 (11): : 2830 - 2843
  • [45] Clinical profile of Trypanosoma cruzi infection in a non-endemic setting: Immigration and Chagas disease in Barcelona (Spain)
    Munoz, Jose
    Gomez i Prat, Jordi
    Gallego, Montserrat
    Gimeno, Fausto
    Trevino, Begona
    Lopez-Chejade, Pablo
    Ribera, Oriol
    Molina, Lluis
    Sanz, Sergi
    Jesus Pinazo, Maria
    Riera, Cristina
    Posada, Elizabeth J.
    Sanz, Gines
    Portus, Montserrat
    Gascon, Joaquim
    ACTA TROPICA, 2009, 111 (01) : 51 - 55
  • [46] Search for a platelet-activating factor receptor in the Trypanosoma cruzi proteome: a potential target for Chagas disease chemotherapy
    Kawano, Daniel Fabio
    da Silva, Vinicius Barreto
    de Melo Jorge, Daniel Macedo
    Tomich de Paula da Silva, Carlos Henrique
    Carvalho, Ivone
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2011, 106 (08): : 957 - 967
  • [47] Immunosuppression and Chagas Disease: A Management Challenge
    Pinazo, Maria-Jesus
    Espinosa, Gerard
    Cortes-Lletget, Cristina
    de Jesus Posada, Elizabeth
    Aldasoro, Edelweiss
    Oliveira, Ines
    Munoz, Jose
    Gallego, Montserrat
    Gascon, Joaquim
    PLOS NEGLECTED TROPICAL DISEASES, 2013, 7 (01):
  • [48] Orally-transmitted Chagas disease
    Teresa Filigheddu, Maria
    Gorgolas, Miguel
    Manuel Ramos, Jose
    MEDICINA CLINICA, 2017, 148 (03): : 125 - 131
  • [49] Chagas Disease: Epidemiology and Barriers to Treatment
    Mills, Roger M.
    AMERICAN JOURNAL OF MEDICINE, 2020, 133 (11) : 1262 - 1265
  • [50] Seroprevalence of Chagas Infection in the Donor Population
    Zaniello, Ben A.
    Kessler, Deborah A.
    Vine, Katherine M.
    Grima, Kathleen M.
    Weisenberg, Scott A.
    PLOS NEGLECTED TROPICAL DISEASES, 2012, 6 (07):